Adiponectin and Its Isoforms in Pathophysiology

Area of Science:

• Endocrinology
• Metabolic Syndrome
• Molecular Biology

Background:

• Adiponectin circulates in various isoforms, with high molecular weight (HMW) adiponectin being the most biologically active.
• HMW adiponectin enhances glucose uptake, insulin sensitivity, and fatty acid oxidation.
• Obesity disrupts adiponectin isoform formation, inversely correlating with metabolic disease markers.

Purpose of the Study:

• To review adiponectin isoform formation and function under physiological conditions.
• To highlight disruptions in adiponectin isoform formation in obesity and related pathologies.
• To discuss the role of adiponectin isoforms in inflammation, cardiac and kidney disease, and their association with mortality.

Main Methods:

• Literature review focusing on adiponectin isoform physiology, pathophysiology, and measurement.
• Synthesis of existing data on adiponectin's role in metabolic health, inflammation, and disease.
• Analysis of challenges and future directions in adiponectin isoform measurement.

Main Results:

• Adiponectin isoforms are critical regulators of glucose and lipid metabolism.
• Obesity-induced changes in adiponectin isoforms are linked to insulin resistance and inflammation.
• Adiponectin isoforms act as acute-phase reactants, influencing inflammatory responses in various diseases.
• A U-shaped association exists between adiponectin levels and mortality.
• Measurement of adiponectin isoforms is complex and lacks a gold standard.

Conclusions:

• Adiponectin isoforms play a vital role in metabolic regulation and inflammation.
• Disrupted adiponectin isoform balance in obesity contributes to pathological conditions.
• Accurate measurement of adiponectin isoforms is essential for understanding their pathophysiological roles and clinical implications.
• Further research is needed to overcome measurement challenges and clarify adiponectin's complex associations with disease and mortality.